tm logo

Monitor this mark

View On USPTO

INTRAROSA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 08 Apr 2024

Last Applicant/ Owned by

MYRIEL PHARMACEUTICALS, LLC

200 CROSSING BOULEVARD

BRIDGEWATER

NJ

08807

Serial Number

86763598 filed on 21st Sep 2015

Registration Number

5311971 registered on 17th Oct 2017

in the Principal Register

Correspondent Address

Mark A. Mazza

Mark A. Mazza Eckert Seamans Cherin & Mellott, LLC

Pittsburgh, PA 15219

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

INTRAROSA

Pharmaceutical preparations for the prevention and treatment of vaginal atrophy, decreased libido and sexual dysfunction

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the prevention and treatment of vaginal atrophy, decreased libido and sexual dysfunction

First Use Date in General

17th Jul 2017

First Use Date in Commerce

17th Jul 2017

Mark Details

Serial Number

No 86763598

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 500879-00116

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
04th Dec 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
25th Jun 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
25th Jun 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25th Jun 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08th Apr 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08th Apr 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08th Apr 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12th Oct 2023TEAS SECTION 8 & 15 RECEIVED
26th Jul 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17th Oct 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED